What is SelfDecode?
SelfDecode operates as a prominent DNA testing service, delivering tailored health recommendations grounded in an individual's genetic predispositions. The company offers a comprehensive suite of reports, including analyses of methylation pathways, longevity screening, and medication compatibility, all designed to guide users toward optimized lifestyle choices. By leveraging genetic data, SelfDecode provides actionable insights for consumers, healthcare practitioners, and businesses alike, aiming to empower individuals in managing their health proactively. With a user base exceeding 200,000 individuals and the trust of over 2,000 doctors, SelfDecode is a recognized leader in the direct-to-consumer genetic health reporting market.
How much funding has SelfDecode raised?
SelfDecode has raised a total of $8M across 1 funding round:
Other Financing Round
$8M
Other Financing Round (2021): $8M with participation from Igor Lychagov and Dan Magnuszewski
Key Investors in SelfDecode
Igor Lychagov
Igor Lychagov is an individual investor participating in the latest funding round, likely bringing strategic insights to SelfDecode's growth.
Dan Magnuszewski
Dan Magnuszewski, an individual investor, has contributed to SelfDecode's recent financing, indicating confidence in the company's innovative approach to personalized health.
What's next for SelfDecode?
The recent major enterprise-level funding positions SelfDecode for accelerated expansion and further development of its AI-driven health coaching platform. This strategic investment is expected to fuel advancements in genetic data analysis and the enhancement of personalized health recommendations. The company's focus on actionable genetic insights, combined with its growing user and practitioner base, suggests a strong potential for market leadership in the burgeoning field of personalized genomics and preventative healthcare.
See full SelfDecode company page
